aap Implantate AG (“aap”) today completed the sale of 100% of the company shares in its subsidiary aapBiomaterials GmbH. The buyer is Keensight Capital, a leading player in European Growth Private Equity. By completing this transaction, aap receives proceeds of about EUR 36.6 million. After deduction of the estimated transaction costs the net inflow amounts […]